The global market for Viscosupplementation was estimated at US$5.2 Billion in 2023 and is projected to reach US$8.8 Billion by 2030, growing at a CAGR of 7.8% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. ![Viscosupplementation Market]( "Viscosupplementation Market")
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Single Injection Viscosupplementation segment, which is expected to reach US$4.9 Billion by 2030 with a CAGR of a 8.5%. The Three Injection Viscosupplementation segment is also set to grow at 7.3% CAGR for the next 7-year period.
- Regional Analysis: Gain insights into the U.S. market, estimated at $1.4 Billion in 2023, and China, forecasted to grow at an impressive 11.6% CAGR to reach $2.2 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Viscosupplementation Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Viscosupplementation Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Viscosupplementation Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players such as Allergan PLC, Anika Therapeutics SRL, Contipro a.s., and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Select Competitors (Total 46 Featured):
- Allergan PLC
- Anika Therapeutics SRL
- Contipro a.s.
- DePuy Synthes
- F. Hoffmann-La Roche AG
- Ferring Pharmaceuticals, Inc.
- Galderma SA
- Lifecore Biomedical LLC
- Merz Aesthetics
- Mylan Pharmaceutical Pvt. Ltd.
- Nordic Drugs
- Sanofi SA
- Shanghai Jingfeng Pharmaceutical Co., Ltd
- Smith & Nephew PLC
- TRB Chemedica International SA
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERSIII. MARKET ANALYSISIV. COMPETITION
1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Viscosupplementation - Global Key Competitors Percentage Market Share in 2024 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
- Global Economic Update
4. GLOBAL MARKET PERSPECTIVE
- TABLE 1: World Recent Past, Current & Future Analysis for Viscosupplementation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 2: World Historic Review for Viscosupplementation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 3: World 16-Year Perspective for Viscosupplementation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
- TABLE 4: World Recent Past, Current & Future Analysis for Single Injection by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 5: World Historic Review for Single Injection by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 6: World 16-Year Perspective for Single Injection by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- TABLE 7: World Recent Past, Current & Future Analysis for Three Injection by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 8: World Historic Review for Three Injection by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 9: World 16-Year Perspective for Three Injection by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- TABLE 10: World Recent Past, Current & Future Analysis for Five Injection by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 11: World Historic Review for Five Injection by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 12: World 16-Year Perspective for Five Injection by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- TABLE 13: World Viscosupplementation Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
UNITED STATES
- Viscosupplementation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
- TABLE 14: USA Recent Past, Current & Future Analysis for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 15: USA Historic Review for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 16: USA 16-Year Perspective for Viscosupplementation by Segment - Percentage Breakdown of Value Sales for Single Injection, Three Injection and Five Injection for the Years 2014, 2024 & 2030
CANADA
- TABLE 17: Canada Recent Past, Current & Future Analysis for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 18: Canada Historic Review for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 19: Canada 16-Year Perspective for Viscosupplementation by Segment - Percentage Breakdown of Value Sales for Single Injection, Three Injection and Five Injection for the Years 2014, 2024 & 2030
JAPAN
- Viscosupplementation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
- TABLE 20: Japan Recent Past, Current & Future Analysis for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 21: Japan Historic Review for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 22: Japan 16-Year Perspective for Viscosupplementation by Segment - Percentage Breakdown of Value Sales for Single Injection, Three Injection and Five Injection for the Years 2014, 2024 & 2030
CHINA
- Viscosupplementation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
- TABLE 23: China Recent Past, Current & Future Analysis for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 24: China Historic Review for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 25: China 16-Year Perspective for Viscosupplementation by Segment - Percentage Breakdown of Value Sales for Single Injection, Three Injection and Five Injection for the Years 2014, 2024 & 2030
EUROPE
- Viscosupplementation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
- TABLE 26: Europe Recent Past, Current & Future Analysis for Viscosupplementation by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 27: Europe Historic Review for Viscosupplementation by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 28: Europe 16-Year Perspective for Viscosupplementation by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
- TABLE 29: Europe Recent Past, Current & Future Analysis for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 30: Europe Historic Review for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 31: Europe 16-Year Perspective for Viscosupplementation by Segment - Percentage Breakdown of Value Sales for Single Injection, Three Injection and Five Injection for the Years 2014, 2024 & 2030
FRANCE
- Viscosupplementation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
- TABLE 32: France Recent Past, Current & Future Analysis for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 33: France Historic Review for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 34: France 16-Year Perspective for Viscosupplementation by Segment - Percentage Breakdown of Value Sales for Single Injection, Three Injection and Five Injection for the Years 2014, 2024 & 2030
GERMANY
- Viscosupplementation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
- TABLE 35: Germany Recent Past, Current & Future Analysis for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 36: Germany Historic Review for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 37: Germany 16-Year Perspective for Viscosupplementation by Segment - Percentage Breakdown of Value Sales for Single Injection, Three Injection and Five Injection for the Years 2014, 2024 & 2030
ITALY
- TABLE 38: Italy Recent Past, Current & Future Analysis for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 39: Italy Historic Review for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 40: Italy 16-Year Perspective for Viscosupplementation by Segment - Percentage Breakdown of Value Sales for Single Injection, Three Injection and Five Injection for the Years 2014, 2024 & 2030
UNITED KINGDOM
- Viscosupplementation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
- TABLE 41: UK Recent Past, Current & Future Analysis for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 42: UK Historic Review for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 43: UK 16-Year Perspective for Viscosupplementation by Segment - Percentage Breakdown of Value Sales for Single Injection, Three Injection and Five Injection for the Years 2014, 2024 & 2030
SPAIN
- TABLE 44: Spain Recent Past, Current & Future Analysis for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 45: Spain Historic Review for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 46: Spain 16-Year Perspective for Viscosupplementation by Segment - Percentage Breakdown of Value Sales for Single Injection, Three Injection and Five Injection for the Years 2014, 2024 & 2030
RUSSIA
- TABLE 47: Russia Recent Past, Current & Future Analysis for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 48: Russia Historic Review for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 49: Russia 16-Year Perspective for Viscosupplementation by Segment - Percentage Breakdown of Value Sales for Single Injection, Three Injection and Five Injection for the Years 2014, 2024 & 2030
REST OF EUROPE
- TABLE 50: Rest of Europe Recent Past, Current & Future Analysis for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 51: Rest of Europe Historic Review for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 52: Rest of Europe 16-Year Perspective for Viscosupplementation by Segment - Percentage Breakdown of Value Sales for Single Injection, Three Injection and Five Injection for the Years 2014, 2024 & 2030
ASIA-PACIFIC
- Viscosupplementation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
- TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Viscosupplementation by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 54: Asia-Pacific Historic Review for Viscosupplementation by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 55: Asia-Pacific 16-Year Perspective for Viscosupplementation by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
- TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 57: Asia-Pacific Historic Review for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 58: Asia-Pacific 16-Year Perspective for Viscosupplementation by Segment - Percentage Breakdown of Value Sales for Single Injection, Three Injection and Five Injection for the Years 2014, 2024 & 2030
AUSTRALIA
- Viscosupplementation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
- TABLE 59: Australia Recent Past, Current & Future Analysis for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 60: Australia Historic Review for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 61: Australia 16-Year Perspective for Viscosupplementation by Segment - Percentage Breakdown of Value Sales for Single Injection, Three Injection and Five Injection for the Years 2014, 2024 & 2030
INDIA
- Viscosupplementation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
- TABLE 62: India Recent Past, Current & Future Analysis for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 63: India Historic Review for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 64: India 16-Year Perspective for Viscosupplementation by Segment - Percentage Breakdown of Value Sales for Single Injection, Three Injection and Five Injection for the Years 2014, 2024 & 2030
SOUTH KOREA
- TABLE 65: South Korea Recent Past, Current & Future Analysis for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 66: South Korea Historic Review for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 67: South Korea 16-Year Perspective for Viscosupplementation by Segment - Percentage Breakdown of Value Sales for Single Injection, Three Injection and Five Injection for the Years 2014, 2024 & 2030
REST OF ASIA-PACIFIC
- TABLE 68: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 69: Rest of Asia-Pacific Historic Review for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 70: Rest of Asia-Pacific 16-Year Perspective for Viscosupplementation by Segment - Percentage Breakdown of Value Sales for Single Injection, Three Injection and Five Injection for the Years 2014, 2024 & 2030
LATIN AMERICA
- Viscosupplementation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
- TABLE 71: Latin America Recent Past, Current & Future Analysis for Viscosupplementation by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 72: Latin America Historic Review for Viscosupplementation by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 73: Latin America 16-Year Perspective for Viscosupplementation by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
- TABLE 74: Latin America Recent Past, Current & Future Analysis for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 75: Latin America Historic Review for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 76: Latin America 16-Year Perspective for Viscosupplementation by Segment - Percentage Breakdown of Value Sales for Single Injection, Three Injection and Five Injection for the Years 2014, 2024 & 2030
ARGENTINA
- TABLE 77: Argentina Recent Past, Current & Future Analysis for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 78: Argentina Historic Review for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 79: Argentina 16-Year Perspective for Viscosupplementation by Segment - Percentage Breakdown of Value Sales for Single Injection, Three Injection and Five Injection for the Years 2014, 2024 & 2030
BRAZIL
- TABLE 80: Brazil Recent Past, Current & Future Analysis for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 81: Brazil Historic Review for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 82: Brazil 16-Year Perspective for Viscosupplementation by Segment - Percentage Breakdown of Value Sales for Single Injection, Three Injection and Five Injection for the Years 2014, 2024 & 2030
MEXICO
- TABLE 83: Mexico Recent Past, Current & Future Analysis for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 84: Mexico Historic Review for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 85: Mexico 16-Year Perspective for Viscosupplementation by Segment - Percentage Breakdown of Value Sales for Single Injection, Three Injection and Five Injection for the Years 2014, 2024 & 2030
REST OF LATIN AMERICA
- TABLE 86: Rest of Latin America Recent Past, Current & Future Analysis for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 87: Rest of Latin America Historic Review for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 88: Rest of Latin America 16-Year Perspective for Viscosupplementation by Segment - Percentage Breakdown of Value Sales for Single Injection, Three Injection and Five Injection for the Years 2014, 2024 & 2030
MIDDLE EAST
- Viscosupplementation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
- TABLE 89: Middle East Recent Past, Current & Future Analysis for Viscosupplementation by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 90: Middle East Historic Review for Viscosupplementation by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 91: Middle East 16-Year Perspective for Viscosupplementation by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
- TABLE 92: Middle East Recent Past, Current & Future Analysis for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 93: Middle East Historic Review for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 94: Middle East 16-Year Perspective for Viscosupplementation by Segment - Percentage Breakdown of Value Sales for Single Injection, Three Injection and Five Injection for the Years 2014, 2024 & 2030
IRAN
- TABLE 95: Iran Recent Past, Current & Future Analysis for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 96: Iran Historic Review for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 97: Iran 16-Year Perspective for Viscosupplementation by Segment - Percentage Breakdown of Value Sales for Single Injection, Three Injection and Five Injection for the Years 2014, 2024 & 2030
ISRAEL
- TABLE 98: Israel Recent Past, Current & Future Analysis for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 99: Israel Historic Review for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 100: Israel 16-Year Perspective for Viscosupplementation by Segment - Percentage Breakdown of Value Sales for Single Injection, Three Injection and Five Injection for the Years 2014, 2024 & 2030
SAUDI ARABIA
- TABLE 101: Saudi Arabia Recent Past, Current & Future Analysis for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 102: Saudi Arabia Historic Review for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 103: Saudi Arabia 16-Year Perspective for Viscosupplementation by Segment - Percentage Breakdown of Value Sales for Single Injection, Three Injection and Five Injection for the Years 2014, 2024 & 2030
UNITED ARAB EMIRATES
- TABLE 104: UAE Recent Past, Current & Future Analysis for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 105: UAE Historic Review for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 106: UAE 16-Year Perspective for Viscosupplementation by Segment - Percentage Breakdown of Value Sales for Single Injection, Three Injection and Five Injection for the Years 2014, 2024 & 2030
REST OF MIDDLE EAST
- TABLE 107: Rest of Middle East Recent Past, Current & Future Analysis for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 108: Rest of Middle East Historic Review for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 109: Rest of Middle East 16-Year Perspective for Viscosupplementation by Segment - Percentage Breakdown of Value Sales for Single Injection, Three Injection and Five Injection for the Years 2014, 2024 & 2030
AFRICA
- Viscosupplementation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
- TABLE 110: Africa Recent Past, Current & Future Analysis for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 111: Africa Historic Review for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 112: Africa 16-Year Perspective for Viscosupplementation by Segment - Percentage Breakdown of Value Sales for Single Injection, Three Injection and Five Injection for the Years 2014, 2024 & 2030
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Allergan PLC
- Anika Therapeutics SRL
- Contipro a.s.
- DePuy Synthes
- F. Hoffmann-La Roche AG
- Ferring Pharmaceuticals, Inc.
- Galderma SA
- Lifecore Biomedical LLC
- Merz Aesthetics
- Mylan Pharmaceutical Pvt. Ltd.
- Nordic Drugs
- Sanofi SA
- Shanghai Jingfeng Pharmaceutical Co., Ltd
- Smith & Nephew PLC
- TRB Chemedica International SA
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 196 |
| Published | November 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 5.2 Billion |
| Forecasted Market Value ( USD | $ 8.8 Billion |
| Compound Annual Growth Rate | 7.8% |
| Regions Covered | Global |
